Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
136.73 MTWD
123.13 MTWD
424.56 M
Om TAIGEN BIOPHARMACEUTICALS HLDGS LTD
Sektor
Bransch
VD
Kuo Long Huang
Webbplats
Huvudkvarter
Taipei
Grundat
2001
ISIN
KYG866171005
FIGI
BBG0055NWZ45
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
